Su Chin Heo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Su Chin Heo has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Yongho Bae
University at Buffalo
11 shared publications - Se-Hwan Lee
McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
8 shared publications Bat-Ider Tumenbayar
McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
7 shared publicationsEllen Y. Zhang
University of Pennsylvania
6 shared publicationsJaeun Jung
McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
6 shared publicationsSe-Hwan Lee
McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
6 shared publications
Latest Publications
- 21 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (34)
Engineering a biomimetic multiphasic suture anchor system for enhanced rotator cuff enthesis regeneration
The rotator cuff plays a vital role in shoulder movement and joint stability. Unfortunately, tears at the rotator cuff enthesis are common and frequently lead to retears after surgical intervention, particularly at the suture location and its anchor sites. These failures are typically due to the inability of current surgical treatments to mimic the native tissue complexity and provide the necessary metabolic, bioactive, and biophysical cues for effective enthesis regeneration. In this study, we engineered a biomimetic multiphasic scaffold system (BMS) to integrate with conventional suture anchor systems and deliver spatially organized structural and biological cues to enhance enthesis regeneration. The BMS consists of three distinct phases: Phase 1 features an aligned, nanofibrous decellularized tendon extracellular matrix (dECM) combined with “stiff” methacrylated hyaluronic acid (MeHA); phase 2 incorporates nonaligned, nanofibrous dECM with “soft” MeHA; and phase 3 uses a porous, bioenergetic, citrate-based composite scaffold for bone integration. In vitro, the BMS notably enhanced tenogenic, fibrochondrogenic, and chondrogenic differentiation, facilitating zone-specific rotator cuff enthesis regeneration. Further, in vivo, the BMS promoted successful integrative healing, forming distinct tendon, fibrocartilage, and bone regions at the repair site. This advanced multiphasic scaffold closely replicates native tissue properties, offering a promising strategy to improve rotator cuff repair. Its integration with conventional suture anchors provides an innovative design that enhances mechanical fixation and guides enthesis healing to reduce retear rates. Broadly, this platform offers a versatile solution for biointegrative repair strategies across complex soft-to-hard tissue interfaces.
- 21 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (34)
Engineering a biomimetic multiphasic suture anchor system for enhanced rotator cuff enthesis regeneration
The rotator cuff plays a vital role in shoulder movement and joint stability. Unfortunately, tears at the rotator cuff enthesis are common and frequently lead to retears after surgical intervention, particularly at the suture location and its anchor sites. These failures are typically due to the inability of current surgical treatments to mimic the native tissue complexity and provide the necessary metabolic, bioactive, and biophysical cues for effective enthesis regeneration. In this study, we engineered a biomimetic multiphasic scaffold system (BMS) to integrate with conventional suture anchor systems and deliver spatially organized structural and biological cues to enhance enthesis regeneration. The BMS consists of three distinct phases: Phase 1 features an aligned, nanofibrous decellularized tendon extracellular matrix (dECM) combined with “stiff” methacrylated hyaluronic acid (MeHA); phase 2 incorporates nonaligned, nanofibrous dECM with “soft” MeHA; and phase 3 uses a porous, bioenergetic, citrate-based composite scaffold for bone integration. In vitro, the BMS notably enhanced tenogenic, fibrochondrogenic, and chondrogenic differentiation, facilitating zone-specific rotator cuff enthesis regeneration. Further, in vivo, the BMS promoted successful integrative healing, forming distinct tendon, fibrocartilage, and bone regions at the repair site. This advanced multiphasic scaffold closely replicates native tissue properties, offering a promising strategy to improve rotator cuff repair. Its integration with conventional suture anchors provides an innovative design that enhances mechanical fixation and guides enthesis healing to reduce retear rates. Broadly, this platform offers a versatile solution for biointegrative repair strategies across complex soft-to-hard tissue interfaces.
- Open Access
- 12 July 2026
- Published by Wiley in Advanced Materials Interfaces
- Vol. 13 (17) , e00012
Dynamic Mechanical Loading Modulates Extracellular Vesicle Production and Cargo in Meniscus Fibrochondrocytes
The meniscus is a fibrocartilaginous tissue critical for knee stability and load distribution, but its poor healing capacity makes regeneration after injury a major clinical challenge. Extracellular vesicles (EVs) are emerging as promising cell‐free therapeutics for tissue regeneration. However, their clinical translation remains limited by low yield and variable bioactivity. This study investigates how dynamic mechanical loading regulates the production, composition, and function of meniscus fibrochondrocyte‐derived EVs (MFC‐EVs). Using a custom bioreactor system, cells are subjected to physiologically relevant cyclic tensile loading. Mechanical stimulation significantly increases EV production, likely through the ESCRT‐independent pathway, without altering vesicle size or tetraspanin expression. “Mechanically primed” EVs enhance aggrecan expression in recipient mesenchymal stromal cells (MSCs), mirroring the loading‐response phenotype of their source cells. Proteomic profiling identifies 380 unique proteins across all EV groups, with primed EVs enriched in extracellular matrix‐ and cytoskeleton‐associated proteins, along with pathways related to tissue morphogenesis, cell migration, and cartilage development. Together, these findings show that physiologic mechanical loading enhances MFC‐EV yield and is associated with distinct EV cargo profiles and recipient MSC gene expression responses. This work provides a scalable, biologically inspired strategy for engineering EV‐based approaches with potential applications in meniscus repair and musculoskeletal regeneration.
- 12 July 2026
- Published by Wiley in Advanced Materials Interfaces
- Vol. 13 (17) , e00012
Open AccessDynamic Mechanical Loading Modulates Extracellular Vesicle Production and Cargo in Meniscus Fibrochondrocytes
The meniscus is a fibrocartilaginous tissue critical for knee stability and load distribution, but its poor healing capacity makes regeneration after injury a major clinical challenge. Extracellular vesicles (EVs) are emerging as promising cell‐free therapeutics for tissue regeneration. However, their clinical translation remains limited by low yield and variable bioactivity. This study investigates how dynamic mechanical loading regulates the production, composition, and function of meniscus fibrochondrocyte‐derived EVs (MFC‐EVs). Using a custom bioreactor system, cells are subjected to physiologically relevant cyclic tensile loading. Mechanical stimulation significantly increases EV production, likely through the ESCRT‐independent pathway, without altering vesicle size or tetraspanin expression. “Mechanically primed” EVs enhance aggrecan expression in recipient mesenchymal stromal cells (MSCs), mirroring the loading‐response phenotype of their source cells. Proteomic profiling identifies 380 unique proteins across all EV groups, with primed EVs enriched in extracellular matrix‐ and cytoskeleton‐associated proteins, along with pathways related to tissue morphogenesis, cell migration, and cartilage development. Together, these findings show that physiologic mechanical loading enhances MFC‐EV yield and is associated with distinct EV cargo profiles and recipient MSC gene expression responses. This work provides a scalable, biologically inspired strategy for engineering EV‐based approaches with potential applications in meniscus repair and musculoskeletal regeneration.
- Open Access
- 9 June 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Hyperactive BMP and mechanosignaling remodel chromatin to drive aberrant osteogenesis in Fibrodysplasia Ossificans Progressiva
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which a recurrent ACVR1 (R206H) mutation drives progressive heterotopic ossification (HO). Although hypersensitive bone morphogenetic protein (BMP) signaling is well established, the mechanisms by which this mutation stabilizes a pro-osteogenic cell state remain unclear. Here, we integrated super-resolution stochastic optical reconstruction microscopy (STORM), transposase-accessible chromatin with sequencing (ATAC-Seq), and RNA sequencing (RNA-Seq) to determine how Acvr1R206H remodels chromatin to influence lineage commitment. Mutant mouse embryonic fibroblasts exhibited globally decondensed chromatin and enhanced accessibility at developmental and osteogenic loci, accompanied by transcriptional programs enriched for ossification, extracellular matrix organization, and cell adhesion. Upon BMP stimulation, Acvr1R206H/+ cells exhibited exaggerated chromatin remodeling, revealing markedly heightened ligand sensitivity. Notably, pharmacological inhibition of Rho/ROCK or BMP-SMAD signaling restored chromatin condensation, demonstrating that these chromatin alterations are dynamic and reversible. Together, these findings show that Acvr1R206H establishes a pro-osteogenic chromatin landscape through convergent Rho/ROCK-dependent mechanotransduction and BMP-dependent pathways, revealing potential therapeutic opportunities to prevent pathological bone formation in FOP.
- 9 June 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Open AccessHyperactive BMP and mechanosignaling remodel chromatin to drive aberrant osteogenesis in Fibrodysplasia Ossificans Progressiva
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which a recurrent ACVR1 (R206H) mutation drives progressive heterotopic ossification (HO). Although hypersensitive bone morphogenetic protein (BMP) signaling is well established, the mechanisms by which this mutation stabilizes a pro-osteogenic cell state remain unclear. Here, we integrated super-resolution stochastic optical reconstruction microscopy (STORM), transposase-accessible chromatin with sequencing (ATAC-Seq), and RNA sequencing (RNA-Seq) to determine how Acvr1R206H remodels chromatin to influence lineage commitment. Mutant mouse embryonic fibroblasts exhibited globally decondensed chromatin and enhanced accessibility at developmental and osteogenic loci, accompanied by transcriptional programs enriched for ossification, extracellular matrix organization, and cell adhesion. Upon BMP stimulation, Acvr1R206H/+ cells exhibited exaggerated chromatin remodeling, revealing markedly heightened ligand sensitivity. Notably, pharmacological inhibition of Rho/ROCK or BMP-SMAD signaling restored chromatin condensation, demonstrating that these chromatin alterations are dynamic and reversible. Together, these findings show that Acvr1R206H establishes a pro-osteogenic chromatin landscape through convergent Rho/ROCK-dependent mechanotransduction and BMP-dependent pathways, revealing potential therapeutic opportunities to prevent pathological bone formation in FOP.
- Open Access
Reprogramming Dedifferentiation Regulatory Networks Preserves Human Chondrocyte Phenotypes
Chondrocyte-based cartilage repair strategies such as autologous chondrocyte implantation (ACI) require extensive in vitro expansion to obtain clinically relevant cell numbers. However, this expansion step progressively drives chondrocyte dedifferentiation, reducing matrix-forming capacity and contributing to variable repair outcomes. To better understand this process, we used single-nucleus multiome profiling (snRNA-Seq + snATAC-Seq) to define the transcriptional and chromatin accessibility programs underlying human chondrocyte dedifferentiation during expansion. Multiome integration across passages revealed a continuous dedifferentiation trajectory accompanied by coordinated remodeling of gene expression and chromatin accessibility, identifying chromatin destabilization as an early regulatory event during phenotype loss. Guided by these regulatory signatures, we screened available small-molecule inhibitors targeting candidate pathways and found that Fludarabine most consistently preserved chondrocyte identity during early expansion. Fludarabine was associated with suppression of STAT1-related programs and early stabilization of the chromatin landscape prior to broader transcriptional recovery. Functionally, treated cells demonstrated enhanced matrix-forming capacity in chondrogenic pellet culture and significantly increased nascent protein synthesis in 3D hydrogel culture, with biosynthetic output approaching unexpanded controls by day 21. Together, these findings identify chromatin stability as a key regulatory determinant of expansion-associated chondrocyte dedifferentiation and establish a pharmacologic strategy to preserve chondrocyte functional potency during cell manufacturing for cartilage repair.
Open AccessReprogramming Dedifferentiation Regulatory Networks Preserves Human Chondrocyte Phenotypes
Chondrocyte-based cartilage repair strategies such as autologous chondrocyte implantation (ACI) require extensive in vitro expansion to obtain clinically relevant cell numbers. However, this expansion step progressively drives chondrocyte dedifferentiation, reducing matrix-forming capacity and contributing to variable repair outcomes. To better understand this process, we used single-nucleus multiome profiling (snRNA-Seq + snATAC-Seq) to define the transcriptional and chromatin accessibility programs underlying human chondrocyte dedifferentiation during expansion. Multiome integration across passages revealed a continuous dedifferentiation trajectory accompanied by coordinated remodeling of gene expression and chromatin accessibility, identifying chromatin destabilization as an early regulatory event during phenotype loss. Guided by these regulatory signatures, we screened available small-molecule inhibitors targeting candidate pathways and found that Fludarabine most consistently preserved chondrocyte identity during early expansion. Fludarabine was associated with suppression of STAT1-related programs and early stabilization of the chromatin landscape prior to broader transcriptional recovery. Functionally, treated cells demonstrated enhanced matrix-forming capacity in chondrogenic pellet culture and significantly increased nascent protein synthesis in 3D hydrogel culture, with biosynthetic output approaching unexpanded controls by day 21. Together, these findings identify chromatin stability as a key regulatory determinant of expansion-associated chondrocyte dedifferentiation and establish a pharmacologic strategy to preserve chondrocyte functional potency during cell manufacturing for cartilage repair.
- Open Access
Engineering a Matrix-Preserving Vascular dECM Platform with Tunable Stiffness for In Vitro Vascular Remodeling
Pathologic arterial stiffening is a hallmark of vascular disease that contributes to maladaptive vascular remodeling and neointimal hyperplasia through vascular smooth muscle cell (VSMC) phenotypic switching. Yet, because vascular disease progression is governed by both biomechanical and extracellular matrix (ECM) alterations, existing in vitro models often fail to recapitulate the full complexity of the diseased vascular microenvironment. Here, we developed a bioactive decellularized extracellular matrix (dECM) and methacrylated hyaluronic acid (MeHA) composite scaffold platform with tunable stiffness that preserves native vascular ECM components while enabling controlled investigation of stiffness-dependent cell behavior. Proteomic analyses confirmed retention of key vascular matrisome components, including collagens and glycoproteins, following decellularization. Electrospun vascular dECM scaffolds maintained an aligned fibrous architecture and spanned stiffness ranges representative of healthy and pathologically stiffened arterial microenvironments. Within this matrix-preserving platform, human VSMCs cultured on stiff dECM scaffolds exhibited increased spreading, altered morphology, enhanced nuclear localization of YAP and survivin, and broad transcriptional changes consistent with a shift toward a proliferative, matrix-remodeling VSMC phenotype. Together, this bioactive, matrix-preserving platform enables mechanobiologically relevant modeling of stiffness-driven vascular remodeling and indicates YAP and survivin as candidate regulators of maladaptive VSMC mechanotransduction.
Open AccessEngineering a Matrix-Preserving Vascular dECM Platform with Tunable Stiffness for In Vitro Vascular Remodeling
Pathologic arterial stiffening is a hallmark of vascular disease that contributes to maladaptive vascular remodeling and neointimal hyperplasia through vascular smooth muscle cell (VSMC) phenotypic switching. Yet, because vascular disease progression is governed by both biomechanical and extracellular matrix (ECM) alterations, existing in vitro models often fail to recapitulate the full complexity of the diseased vascular microenvironment. Here, we developed a bioactive decellularized extracellular matrix (dECM) and methacrylated hyaluronic acid (MeHA) composite scaffold platform with tunable stiffness that preserves native vascular ECM components while enabling controlled investigation of stiffness-dependent cell behavior. Proteomic analyses confirmed retention of key vascular matrisome components, including collagens and glycoproteins, following decellularization. Electrospun vascular dECM scaffolds maintained an aligned fibrous architecture and spanned stiffness ranges representative of healthy and pathologically stiffened arterial microenvironments. Within this matrix-preserving platform, human VSMCs cultured on stiff dECM scaffolds exhibited increased spreading, altered morphology, enhanced nuclear localization of YAP and survivin, and broad transcriptional changes consistent with a shift toward a proliferative, matrix-remodeling VSMC phenotype. Together, this bioactive, matrix-preserving platform enables mechanobiologically relevant modeling of stiffness-driven vascular remodeling and indicates YAP and survivin as candidate regulators of maladaptive VSMC mechanotransduction.
- Open Access
Dynamic Mechanical Loading Reprograms Meniscus Cell-Derived Extracellular Vesicles to Enhance Their Regenerative Potency
The meniscus is a fibrocartilaginous tissue critical for knee stability and load distribution, but its poor healing capacity makes regeneration after injury a major clinical challenge. Extracellular vesicles (EVs) are emerging as promising cell-free therapeutics for tissue regeneration. However, their clinical translation remains limited by low yield and variable bioactivity. Here, we investigated how dynamic mechanical loading regulates the production, composition, and function of meniscus fibrochondrocyte-derived EVs (MFC-EVs). Using a custom bioreactor system, cells were subjected to physiologically relevant cyclic tensile loading. Mechanical stimulation significantly increased EV production and secretion, likely through the ESCRT-independent pathway, without altering vesicle size or tetraspanin expression. Functionally, “mechanically primed” EVs enhanced aggrecan expression in recipient mesenchymal stromal cells (MSCs), mirroring the loading-response phenotype of their source cells. Proteomic profiling identified 380 unique proteins across all EV groups, with loaded EVs enriched in extracellular matrix- and cytoskeleton-associated proteins, as well as pathways related to tissue morphogenesis, cell migration, and cartilage development. Together, these findings demonstrate that physiologic mechanical loading enhances both the yield and regenerative potency of MFC-EVs by enriching their cargo with matrix- and development-associated proteins, providing a scalable and biologically inspired approach for engineering high-efficacy EV therapeutics for meniscus repair and musculoskeletal regeneration.
Open AccessDynamic Mechanical Loading Reprograms Meniscus Cell-Derived Extracellular Vesicles to Enhance Their Regenerative Potency
The meniscus is a fibrocartilaginous tissue critical for knee stability and load distribution, but its poor healing capacity makes regeneration after injury a major clinical challenge. Extracellular vesicles (EVs) are emerging as promising cell-free therapeutics for tissue regeneration. However, their clinical translation remains limited by low yield and variable bioactivity. Here, we investigated how dynamic mechanical loading regulates the production, composition, and function of meniscus fibrochondrocyte-derived EVs (MFC-EVs). Using a custom bioreactor system, cells were subjected to physiologically relevant cyclic tensile loading. Mechanical stimulation significantly increased EV production and secretion, likely through the ESCRT-independent pathway, without altering vesicle size or tetraspanin expression. Functionally, “mechanically primed” EVs enhanced aggrecan expression in recipient mesenchymal stromal cells (MSCs), mirroring the loading-response phenotype of their source cells. Proteomic profiling identified 380 unique proteins across all EV groups, with loaded EVs enriched in extracellular matrix- and cytoskeleton-associated proteins, as well as pathways related to tissue morphogenesis, cell migration, and cartilage development. Together, these findings demonstrate that physiologic mechanical loading enhances both the yield and regenerative potency of MFC-EVs by enriching their cargo with matrix- and development-associated proteins, providing a scalable and biologically inspired approach for engineering high-efficacy EV therapeutics for meniscus repair and musculoskeletal regeneration.
- Open Access
Age-Dependent Chromatin Remodeling Drives Inflammatory Dysregulation in Tendon Cells
Aging impairs tissue function and tolerance to cellular stress by reprogramming the behavior of resident cells. With global increases in lifespan, the prevalence of chronic and degenerative musculoskeletal disorders, including tendon degeneration, continues to rise; however, effective interventions to counteract age-related decline remain limited. Here, we investigate how a central age-associated stressor, inflammation, differentially modulates tendon cell behavior derived from young and mature-aged donors. Using super-resolution microscopy to resolve nanoscale chromatin organization in conjunction with epigenomic and transcriptomic profiling, we identify age-dependent regulatory mechanisms that govern inflammatory responsiveness. Mature-aged tendon cells exhibit exaggerated pro-inflammatory and catabolic responses across chromatin, gene expression, and protein signaling levels, characterized by enhanced TNFα receptor organization, elevated accessibility at pro-inflammatory regulatory elements, and robust induction of matrix-degrading enzymes. Notably, the AP-1 transcription factor family emerges as a central age-dependent regulator, displaying distinct motif accessibility patterns that bias mature tenocytes toward inflammatory and degenerative transcriptional programs. Taken together, our findings demonstrate that age-dependent epigenetic priming amplifies inflammatory sensitivity and constrains reparative gene regulation in mature tendon cells. This work provides a mechanistic framework linking chromatin remodeling to tendon degeneration and holds potential to identify epigenetic and transcriptional pathways as potential targets for rejuvenation strategies in aging musculoskeletal tissues.
Open AccessAge-Dependent Chromatin Remodeling Drives Inflammatory Dysregulation in Tendon Cells
Aging impairs tissue function and tolerance to cellular stress by reprogramming the behavior of resident cells. With global increases in lifespan, the prevalence of chronic and degenerative musculoskeletal disorders, including tendon degeneration, continues to rise; however, effective interventions to counteract age-related decline remain limited. Here, we investigate how a central age-associated stressor, inflammation, differentially modulates tendon cell behavior derived from young and mature-aged donors. Using super-resolution microscopy to resolve nanoscale chromatin organization in conjunction with epigenomic and transcriptomic profiling, we identify age-dependent regulatory mechanisms that govern inflammatory responsiveness. Mature-aged tendon cells exhibit exaggerated pro-inflammatory and catabolic responses across chromatin, gene expression, and protein signaling levels, characterized by enhanced TNFα receptor organization, elevated accessibility at pro-inflammatory regulatory elements, and robust induction of matrix-degrading enzymes. Notably, the AP-1 transcription factor family emerges as a central age-dependent regulator, displaying distinct motif accessibility patterns that bias mature tenocytes toward inflammatory and degenerative transcriptional programs. Taken together, our findings demonstrate that age-dependent epigenetic priming amplifies inflammatory sensitivity and constrains reparative gene regulation in mature tendon cells. This work provides a mechanistic framework linking chromatin remodeling to tendon degeneration and holds potential to identify epigenetic and transcriptional pathways as potential targets for rejuvenation strategies in aging musculoskeletal tissues.
- Open Access
Hyperactive BMP and Mechanosignaling Remodel Chromatin to Drive Aberrant Osteogenesis in FOP
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which a recurrent ACVR1 (R206H) mutation drives progressive heterotopic ossification (HO). While aberrant BMP hypersensitivity has been studied, how this mutation enforces a persistent pro-osteogenic state remains unclear. Here, we combined super-resolution stochastic optical reconstruction microscopy (STORM), transposase-accessible chromatin with sequencing (ATAC-Seq), and RNA sequencing (RNA-Seq) to investigate how Acvr1 R206H remodels chromatin to promote osteogenic transcriptional programs. Mutant mouse embryonic fibroblasts (MEFs) exhibited globally decondensed chromatin and increased accessibility at developmental and osteogenic loci enriched for HOX, TEAD, and RUNX motifs. Integration of ATAC-Seq and RNA-Seq data identified transcriptional networks primed for osteochondrogenic gene expression, including ossification, extracellular matrix organization, and cell adhesion pathways, consistent with enhanced BMP–SMAD and mechanotransduction activity. Time-course experiments revealed heightened responses to BMP ligands in Acvr1 R206H/+ MEFs compared to wild-type, highlighting ligand hypersensitivity. Importantly, pharmacological modulation showed that chromatin alterations were dynamic and reversible: activation of Rho/ROCK in wild-type cells reproduced the mutant chromatin state, while inhibition of Rho/ROCK or BMP–SMAD signaling restored condensation to wild-type levels in mutant cells. Together, these findings establish that Acvr1 R206H enforces a pro-osteogenic chromatin landscape through convergent BMP–SMAD and Rho/ROCK signaling, predisposing progenitors to aberrant differentiation trajectories. Our study reframes FOP as a disorder of persistent, but reversible, chromatin states and identifies novel therapeutic opportunities to restore mesenchymal cell homeostasis and prevent pathological bone formation. Significance Statement: Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which a mutation in ACVR1/ALK2 drives progressive heterotopic ossification. However, how this mutation enforces a persistent pro-osteogenic state is unclear. Here, we show that the Acvr1 R206H mutation remodels chromatin architecture and accessibility through hyperactive BMP–SMAD and Rho/ROCK signaling, activating transcription factor networks that drive osteochondrogenic gene expression. These chromatin changes are dynamic and reversible with targeted pathway inhibition, revealing therapeutic potential to restore mesenchymal cell plasticity and prevent pathological bone formation.
Open AccessHyperactive BMP and Mechanosignaling Remodel Chromatin to Drive Aberrant Osteogenesis in FOP
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which a recurrent ACVR1 (R206H) mutation drives progressive heterotopic ossification (HO). While aberrant BMP hypersensitivity has been studied, how this mutation enforces a persistent pro-osteogenic state remains unclear. Here, we combined super-resolution stochastic optical reconstruction microscopy (STORM), transposase-accessible chromatin with sequencing (ATAC-Seq), and RNA sequencing (RNA-Seq) to investigate how Acvr1 R206H remodels chromatin to promote osteogenic transcriptional programs. Mutant mouse embryonic fibroblasts (MEFs) exhibited globally decondensed chromatin and increased accessibility at developmental and osteogenic loci enriched for HOX, TEAD, and RUNX motifs. Integration of ATAC-Seq and RNA-Seq data identified transcriptional networks primed for osteochondrogenic gene expression, including ossification, extracellular matrix organization, and cell adhesion pathways, consistent with enhanced BMP–SMAD and mechanotransduction activity. Time-course experiments revealed heightened responses to BMP ligands in Acvr1 R206H/+ MEFs compared to wild-type, highlighting ligand hypersensitivity. Importantly, pharmacological modulation showed that chromatin alterations were dynamic and reversible: activation of Rho/ROCK in wild-type cells reproduced the mutant chromatin state, while inhibition of Rho/ROCK or BMP–SMAD signaling restored condensation to wild-type levels in mutant cells. Together, these findings establish that Acvr1 R206H enforces a pro-osteogenic chromatin landscape through convergent BMP–SMAD and Rho/ROCK signaling, predisposing progenitors to aberrant differentiation trajectories. Our study reframes FOP as a disorder of persistent, but reversible, chromatin states and identifies novel therapeutic opportunities to restore mesenchymal cell homeostasis and prevent pathological bone formation. Significance Statement: Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which a mutation in ACVR1/ALK2 drives progressive heterotopic ossification. However, how this mutation enforces a persistent pro-osteogenic state is unclear. Here, we show that the Acvr1 R206H mutation remodels chromatin architecture and accessibility through hyperactive BMP–SMAD and Rho/ROCK signaling, activating transcription factor networks that drive osteochondrogenic gene expression. These chromatin changes are dynamic and reversible with targeted pathway inhibition, revealing therapeutic potential to restore mesenchymal cell plasticity and prevent pathological bone formation.
- Open Access
Engineering a Biomimetic Multiphasic Suture Anchor System for Enhanced Rotator Cuff Enthesis Regeneration
Conventional suture anchor methods in rotator cuff repair often fail to replicate the native tendon-to-bone interface, leading to re-tears due to stress concentrations and poor biological integration at anchor sites. To address these challenges, we engineered a biomimetic multiphasic scaffold system (BMS) that integrates with standard suture anchors and deliver spatially organized structural and biological cues to enhance enthesis regeneration. The BMS comprises three distinct phases: aligned nanofibrous decellularized bovine Achilles tendon extracellular matrix (dECM) with ‘stiff’ methacrylated hyaluronic acid (MeHA) for tendon regeneration; nonaligned nanofibrous dECM with ‘soft’ MeHA for fibrocartilage formation; and a porous, citrate-based composite scaffold with bioactive glass for bone integration. In vitro , the BMS facilitated zone-specific tenogenic, fibrochondrogenic, and chondrogenic differentiation. Further, in vivo , it promoted successful integrative healing, forming distinct tendon, fibrocartilage, and bone regions at the repair site. This advanced multiphasic scaffold replicates native tissue properties, offering a promising strategy to improve rotator cuff repair. Its integration with conventional suture anchors provides an innovative design that enhances mechanical fixation and guides enthesis healing to reduce re-tear rates. Broadly, this platform offers a versatile solution for biointegrative repair strategies across complex soft-to-hard tissue interfaces.
Open AccessEngineering a Biomimetic Multiphasic Suture Anchor System for Enhanced Rotator Cuff Enthesis Regeneration
Conventional suture anchor methods in rotator cuff repair often fail to replicate the native tendon-to-bone interface, leading to re-tears due to stress concentrations and poor biological integration at anchor sites. To address these challenges, we engineered a biomimetic multiphasic scaffold system (BMS) that integrates with standard suture anchors and deliver spatially organized structural and biological cues to enhance enthesis regeneration. The BMS comprises three distinct phases: aligned nanofibrous decellularized bovine Achilles tendon extracellular matrix (dECM) with ‘stiff’ methacrylated hyaluronic acid (MeHA) for tendon regeneration; nonaligned nanofibrous dECM with ‘soft’ MeHA for fibrocartilage formation; and a porous, citrate-based composite scaffold with bioactive glass for bone integration. In vitro , the BMS facilitated zone-specific tenogenic, fibrochondrogenic, and chondrogenic differentiation. Further, in vivo , it promoted successful integrative healing, forming distinct tendon, fibrocartilage, and bone regions at the repair site. This advanced multiphasic scaffold replicates native tissue properties, offering a promising strategy to improve rotator cuff repair. Its integration with conventional suture anchors provides an innovative design that enhances mechanical fixation and guides enthesis healing to reduce re-tear rates. Broadly, this platform offers a versatile solution for biointegrative repair strategies across complex soft-to-hard tissue interfaces.
- Open Access
Genetic liability to meniscus degeneration and its comorbidity patterns: a phenome-wide association study in the UK Biobank
Meniscus degeneration is a common knee pathology causing pain, disability, and osteoarthritis. While mechanical factors are established, the contribution of inherited genetic liability to its systemic disease patterns remains unclear. We applied a polygenic risk score (PRS) for meniscus degeneration, derived from FinnGen genome-wide association study (GWAS) results to 323,999 UK Biobank participants and conducted a phenome-wide association study (PRS-PheWAS) across 962 clinical phenotypes. The PRS-PheWAS revealed significant associations beyond musculoskeletal traits, extending to metabolic, cardiovascular, psychiatric, and gastrointestinal domains, indicating broad shared genetic architecture. To support these findings, linkage disequilibrium score regression confirmed strong genetic correlations with osteoarthritis and related arthropathies, and genotype-tissue expression (GTEx) analysis highlighted tissue-specific expression of lead genes (e.g., GDF5, SOX5, BMP6) in connective and metabolic tissues. The results demonstrate that genetic liability to meniscus degeneration extends beyond the knee, sharing pathways with systemic conditions. This systemic genetic architecture underscores the need for integrative management approaches that combine orthopedic care with metabolic and lifestyle interventions.
Open AccessGenetic liability to meniscus degeneration and its comorbidity patterns: a phenome-wide association study in the UK Biobank
Meniscus degeneration is a common knee pathology causing pain, disability, and osteoarthritis. While mechanical factors are established, the contribution of inherited genetic liability to its systemic disease patterns remains unclear. We applied a polygenic risk score (PRS) for meniscus degeneration, derived from FinnGen genome-wide association study (GWAS) results to 323,999 UK Biobank participants and conducted a phenome-wide association study (PRS-PheWAS) across 962 clinical phenotypes. The PRS-PheWAS revealed significant associations beyond musculoskeletal traits, extending to metabolic, cardiovascular, psychiatric, and gastrointestinal domains, indicating broad shared genetic architecture. To support these findings, linkage disequilibrium score regression confirmed strong genetic correlations with osteoarthritis and related arthropathies, and genotype-tissue expression (GTEx) analysis highlighted tissue-specific expression of lead genes (e.g., GDF5, SOX5, BMP6) in connective and metabolic tissues. The results demonstrate that genetic liability to meniscus degeneration extends beyond the knee, sharing pathways with systemic conditions. This systemic genetic architecture underscores the need for integrative management approaches that combine orthopedic care with metabolic and lifestyle interventions.